Literature DB >> 30203485

HDAC1/2-mediated regulation of JNK and ERK phosphorylation in bovine mammary epithelial cells in response to TNF-α.

Samantha S Romanick1,2,3, Kristen Morrill1, Andrew Hostler1, Levi W Evans1,3,4, Yiqiu Shen5, Allison Matsumura5, Haleigh Piotrowski5, Lorrayny G Silva6, Antonio P Faciola6, Bradley S Ferguson1,3.   

Abstract

Bovine mammary epithelial cells (MAC-Ts) are a common cell line for the study of mammary epithelial inflammation; these cells are used to mechanistically elucidate molecular underpinnings that contribute to bovine mastitis. Bovine mastitis is the most prevalent form of disease in dairy cattle that culminates in annual losses of two billion dollars for the US dairy industry. Thus, there is an urgent need for improved therapeutic strategies. Histone deacetylase (HDAC) inhibitors are efficacious in rodent models of inflammation, yet their role in bovine mammary cells remain unclear. HDACs have traditionally been studied in the regulation of nucleosomal DNA, in which deacetylation of histones impact chromatin accessibility and gene expression. Using MAC-T cells stimulated with tumor necrosis factor α (TNF-α) as a model for mammary cell inflammation, we report that inhibition of HDACs1 and 2 (HDAC1/2) attenuated TNF-α-mediated inflammatory gene expression. Of note, we report that HDAC1/2-mediated inflammatory gene expression was partly regulated by c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) phosphorylation. Here, we report that HDAC1/2 inhibition attenuated JNK and ERK activation and thus inflammatory gene expression. These data suggest that HDACs1 and 2 regulate inflammatory gene expression via canonical (i.e., gene expression) and noncanonical (e.g., signaling dependent) mechanisms. Whereas, further studies using primary cell lines and animal models are needed. Our combined data suggest that HDAC1/2-specific inhibitors may prove efficacious for the treatment of bovine mastitis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  HDAC inhibitors; HDACs; MAC-T; bovine inflammation; bovine mammary epithelial cells; histone deacetylases; phosphorylation

Year:  2018        PMID: 30203485      PMCID: PMC6246792          DOI: 10.1002/jcp.27265

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  44 in total

1.  A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts.

Authors:  A O Hueber; M Zörnig; A M Bernard; M Chautan; G Evan
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 2.  Emerging approaches for histone deacetylase inhibitor drug discovery.

Authors:  Clemens Zwergel; Sergio Valente; Claus Jacob; Antonello Mai
Journal:  Expert Opin Drug Discov       Date:  2015-04-20       Impact factor: 6.098

3.  Lipopolysaccharide and lipoteichoic acid induce different innate immune responses in bovine mammary epithelial cells.

Authors:  Ylva Strandberg; Christian Gray; Tony Vuocolo; Laurelea Donaldson; Mary Broadway; Ross Tellam
Journal:  Cytokine       Date:  2005-07-07       Impact factor: 3.861

Review 4.  Mastitis and its impact on structure and function in the ruminant mammary gland.

Authors:  R Michael Akers; Stephen C Nickerson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-04       Impact factor: 2.673

5.  Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension.

Authors:  Douglas D Lemon; Todd R Horn; Maria A Cavasin; Mark Y Jeong; Kurt W Haubold; Carlin S Long; David C Irwin; Sylvia A McCune; Eunhee Chung; Leslie A Leinwand; Timothy A McKinsey
Journal:  J Mol Cell Cardiol       Date:  2011-04-23       Impact factor: 5.000

6.  MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.

Authors:  Marielle Fournel; Claire Bonfils; Yu Hou; Pu Theresa Yan; Marie-Claude Trachy-Bourget; Ann Kalita; Jianhong Liu; Ai-Hua Lu; Nancy Z Zhou; Marie-France Robert; Jeffrey Gillespie; James J Wang; Hélène Ste-Croix; Jubrail Rahil; Sylvain Lefebvre; Oscar Moradei; Daniel Delorme; A Robert Macleod; Jeffrey M Besterman; Zuomei Li
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

Review 7.  Mammary tissue damage during bovine mastitis: causes and control.

Authors:  X Zhao; P Lacasse
Journal:  J Anim Sci       Date:  2007-09-04       Impact factor: 3.159

Review 8.  Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer.

Authors:  Shankar Suman; Pradeep Kumar Sharma; Girish Rai; Sanjay Mishra; Deepika Arora; Prachi Gupta; Yogeshwer Shukla
Journal:  Biochem Biophys Res Commun       Date:  2015-10-29       Impact factor: 3.575

9.  Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

Authors:  Sarah M Williams; Lucy Golden-Mason; Bradley S Ferguson; Katherine B Schuetze; Maria A Cavasin; Kim Demos-Davies; Michael E Yeager; Kurt R Stenmark; Timothy A McKinsey
Journal:  J Mol Cell Cardiol       Date:  2013-12-26       Impact factor: 5.000

10.  Stromal fibroblasts derived from mammary gland of bovine with mastitis display inflammation-specific changes.

Authors:  Qing Chen; Guiliang He; Wenyao Zhang; Tong Xu; Hongliang Qi; Jing Li; Yong Zhang; Ming-Qing Gao
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

View more
  2 in total

1.  Prolactin and Estradiol are Epigenetic Modulators in Bovine Mammary Epithelial Cells during Staphylococcus aureus Infection.

Authors:  María Guadalupe Salgado-Lora; Ivan Medina-Estrada; Joel Edmundo López-Meza; Alejandra Ochoa-Zarzosa
Journal:  Pathogens       Date:  2020-06-28

2.  Protective effects of the notoginsenoside R1 on acute lung injury by regulating the miR-128-2-5p/Tollip signaling pathway in rats with severe acute pancreatitis.

Authors:  Ju He; Ming-Wei Liu; Zhi-Yi Wang; Rong-Jie Shi
Journal:  Innate Immun       Date:  2022-01       Impact factor: 2.680

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.